The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group.
Glomerular IgG staining
IgA nephropathy
Renal prognostic factors
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
28 10 2021
28 10 2021
Historique:
received:
03
05
2021
accepted:
09
09
2021
entrez:
29
10
2021
pubmed:
30
10
2021
medline:
11
3
2022
Statut:
epublish
Résumé
Galactose-deficient IgA1 (Gd-IgA1) has an increased tendency to form immunocomplexes with IgG in the serum, contributing to IgAN pathogenesis by accumulating in the glomerular mesangium. Several studies showed that glomerular IgG deposition in IgAN is an important cause of mesangial proliferation and glomerular damage. This study aims to determine the association of the positivity of IgG and the intensity of IgG staining with a poor renal prognosis. A total of 943 IgAN patients were included in the study. Glomerular IgG staining negative and positive patients were compared using Oxford classification scores, histopathological evaluations, proteinuria, eGFR, albumin, blood pressures. IgG positive patients were classified as (+), (++), (+++) based on their staining intensity, and the association with the prognostic criteria was also evaluated. 81% (n = 764) of the patients were detected as IgG negative, while 19% (n = 179) were positive. Age, gender, body mass index, blood pressure, proteinuria, eGFR, uric acid values were similar in IgG positive and negative patients who underwent biopsy (p > 0.05). Intensity of glomerular IgG positivity was not found to be associated with diastolic and systolic blood pressure, urea, uric acid, age, eGFR, albumin, proteinuria (p > 0.05 for all, r = - 0.084, r = - 0.102, r = - 0.006, r = 0.062, r = 0.014, r = - 0.044, r = - 0.061, r = - 0.066, r = 0.150, respectively). There was no difference for histopathological findings between IgG (+), IgG (++), IgG (+++) groups (for all, p > 0.05). Glomerular IgG negativity and positivity detected by routine IFM in IgAN patients is not associated with poor renal prognostic risk factors.
Sections du résumé
BACKGROUND
Galactose-deficient IgA1 (Gd-IgA1) has an increased tendency to form immunocomplexes with IgG in the serum, contributing to IgAN pathogenesis by accumulating in the glomerular mesangium. Several studies showed that glomerular IgG deposition in IgAN is an important cause of mesangial proliferation and glomerular damage. This study aims to determine the association of the positivity of IgG and the intensity of IgG staining with a poor renal prognosis.
METHODS
A total of 943 IgAN patients were included in the study. Glomerular IgG staining negative and positive patients were compared using Oxford classification scores, histopathological evaluations, proteinuria, eGFR, albumin, blood pressures. IgG positive patients were classified as (+), (++), (+++) based on their staining intensity, and the association with the prognostic criteria was also evaluated.
RESULTS
81% (n = 764) of the patients were detected as IgG negative, while 19% (n = 179) were positive. Age, gender, body mass index, blood pressure, proteinuria, eGFR, uric acid values were similar in IgG positive and negative patients who underwent biopsy (p > 0.05). Intensity of glomerular IgG positivity was not found to be associated with diastolic and systolic blood pressure, urea, uric acid, age, eGFR, albumin, proteinuria (p > 0.05 for all, r = - 0.084, r = - 0.102, r = - 0.006, r = 0.062, r = 0.014, r = - 0.044, r = - 0.061, r = - 0.066, r = 0.150, respectively). There was no difference for histopathological findings between IgG (+), IgG (++), IgG (+++) groups (for all, p > 0.05).
CONCLUSION
Glomerular IgG negativity and positivity detected by routine IFM in IgAN patients is not associated with poor renal prognostic risk factors.
Identifiants
pubmed: 34711174
doi: 10.1186/s12882-021-02560-2
pii: 10.1186/s12882-021-02560-2
pmc: PMC8555045
doi:
Substances chimiques
Immunoglobulin G
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
352Informations de copyright
© 2021. The Author(s).
Références
Nephrol Dial Transplant. 2011 Aug;26(8):2533-6
pubmed: 21273233
Am J Kidney Dis. 1998 Jun;31(6):962-70
pubmed: 9631840
Kidney Int. 2009 Sep;76(5):546-56
pubmed: 19571790
Mod Pathol. 2016 Jul;29(7):743-52
pubmed: 27102346
Clin J Am Soc Nephrol. 2017 Apr 3;12(4):677-686
pubmed: 28159829
Kidney Int. 1984 Apr;25(4):717-29
pubmed: 6482176
J Pediatr. 1990 May;116(5):S78-85
pubmed: 2184209
Kidney Int. 2005 Jul;68(1):167-72
pubmed: 15954905
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Kidney Int. 2017 May;91(5):1014-1021
pubmed: 28341274
Nephron. 1983;34(3):146-53
pubmed: 6348567
Clin Exp Nephrol. 2013 Feb;17(1):73-82
pubmed: 22752397
J Am Soc Nephrol. 2019 Oct;30(10):2017-2026
pubmed: 31444275
Q J Med. 1986 Apr;59(228):363-78
pubmed: 3749442
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Kidney Int. 2000 Jul;58(1):90-9
pubmed: 10886553
Am J Nephrol. 2000 Mar-Apr;20(2):122-8
pubmed: 10773612
Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1458-1465
pubmed: 31511226
Kidney Int. 2001 Sep;60(3):969-73
pubmed: 11532091
Am J Kidney Dis. 1987 May;9(5):404-9
pubmed: 3555015
Nephrol Dial Transplant. 2018 Jul 1;33(7):1168-1175
pubmed: 28992348
Kidney Int. 2001 Mar;59(3):1077-85
pubmed: 11231363